共 50 条
- [31] Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases Journal of Clinical Immunology, 2006, 26 : 265 - 273
- [33] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15): : S475 - S481
- [34] The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency TRENDS IN PEDIATRICS, 2023, 4 (02): : 103 - 108
- [36] Patient Preferences for Faster Home-Based Subcutaneous Immunoglobulin Infusion Therapy and the Effect on Adverse Events PATIENT PREFERENCE AND ADHERENCE, 2025, 19 : 615 - 621
- [37] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases Journal of Clinical Immunology, 2014, 34 : 204 - 211
- [39] Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases Advances in Therapy, 2023, 40 : 5168 - 5187